Carcinoma in situ of left eye
ICD-10 D09.22 is a billable code used to indicate a diagnosis of carcinoma in situ of left eye.
Carcinoma in situ (CIS) of the left eye refers to a localized form of cancer where abnormal cells are present but have not invaded surrounding tissues. This condition is often detected during routine eye examinations or imaging studies. The left eye may exhibit changes in the conjunctiva, cornea, or other ocular structures, which can be identified through various diagnostic methods, including biopsy and histopathological examination. CIS is considered a precursor to invasive cancer, and while it is not life-threatening in its current state, it requires careful monitoring and management to prevent progression to invasive carcinoma. Surveillance protocols typically involve regular ophthalmologic evaluations, imaging studies, and possibly topical treatments or surgical interventions, depending on the severity and characteristics of the lesions. The risk of progression to invasive cancer varies based on factors such as the type of carcinoma, patient demographics, and underlying health conditions. Early detection and intervention are crucial in managing this condition effectively.
Detailed ocular examination findings, biopsy results, and treatment plans.
Routine screenings, management of ocular lesions, and follow-up for carcinoma in situ.
Ensure clear documentation of the type and location of carcinoma, as well as any treatment provided.
Comprehensive cancer staging, treatment history, and follow-up care plans.
Management of patients with a history of ocular carcinoma and coordination of care with ophthalmologists.
Documentation should reflect the multidisciplinary approach to treatment and surveillance.
Used when excising a carcinoma in situ of the left eye.
Document the size and location of the lesion, as well as the pathology results.
Ophthalmologists should ensure that the excision is documented as related to the carcinoma in situ.
Carcinoma in situ refers to cancer cells that have not invaded surrounding tissues, while invasive carcinoma has spread beyond the original site into adjacent tissues.
